SID 2026Abstract 0707
Postmarketing safety analysis of bimekizumab for hidradenitis suppurativa
Alomary SA, Baker N, Ogunleye T, Taylor SC
SID Annual Meeting 2026Health disparitiesChicago, 13–16 May 2026 · published in JID 21 Jul 2026
Topics: Hidradenitis suppurativaBiologics
Abstract
The abstract’s text is on the JID website.
DOI 10.1016/j.jid.2026.06.738 · Not in PubMed: details from Crossref